Arcutis Biotherapeutics (ARQT) Gross Margin (2022 - 2026)
Arcutis Biotherapeutics' Gross Margin came in at 91.58% for Q2 2026, up 0.77 percentage points from 90.81% a year earlier and up 0.86 percentage points from the prior quarter.
Powered by 
Analysis
Arcutis Biotherapeutics (ARQT) Gross Margin (2022 - 2026) Analysis & Trends
Over the trailing twelve months to Jun 30, 2026, Arcutis Biotherapeutics reported Gross Margin of 91.14%, up 2.05 percentage points year-over-year; for FY2025, it was 90.24%, down 0.03 percentage points from FY2024.
- Gross Margin carries a three-year change of +10.70 percentage points (FY2022 to FY2025).
- Going back by year, Gross Margin was 90.27% in FY2024 (-1.37 pp), 91.63% in FY2023 (+12.09 pp) and 79.54% in FY2022.
- The Q2 2026 figure represents the highest quarterly Gross Margin since Q1 2024.
- Year-over-year, Gross Margin has increased for five consecutive quarters, with an average year-over-year change of +0.25 percentage points over the last eight quarters.
- The fastest year-over-year change in Gross Margin over five years came in Q3 2023 (a gain of 34.00 percentage points), and the weakest in Q3 2024 (a drop of 9.19 percentage points).
- Business Quant data shows ARQT's Gross Margin at 90.72% (Q1 2026), 90.97% (Q4 2025) and 91.25% (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 68.19% |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 74.74% |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 73.54% |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 78.02% |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 83.60% |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 72.04% |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 79.76% |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 72.78% |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 85.33% |
| 10 | Arcutis Biotherapeutics | 3.43 Bn | 2.72 Bn | 118.92 Mn | 91.58% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 91.58% |
| Mar 31, 2026 | 90.72% |
| Dec 31, 2025 | 90.97% |
| Sep 30, 2025 | 91.25% |
| Jun 30, 2025 | 90.81% |
| Mar 31, 2025 | 86.59% |
| Dec 31, 2024 | 90.32% |
| Sep 30, 2024 | 87.70% |
| Jun 30, 2024 | 88.77% |
| Mar 31, 2024 | 93.43% |
| Dec 31, 2023 | 83.39% |
| Sep 30, 2023 | 96.90% |
| Jun 30, 2023 | 85.05% |
| Mar 31, 2023 | 71.84% |
| Dec 31, 2022 | 83.62% |
| Sep 30, 2022 | 62.90% |
API Access
Arcutis Biotherapeutics Gross Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=gross-margin&ticker=ARQT&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "gross-margin", "ticker": "ARQT", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=gross-margin&ticker=ARQT&period=max&api_key=YOUR_API_KEY");
const data = await res.json();